-
My Account
My Account
BSE Live
Apr 20, 16:00Prev. Close
399.25
Open Price
408.00
Bid Price (Qty.)
479.10 (10829)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:58Prev. Close
399.35
Open Price
405.30
Bid Price (Qty.)
477.70 (45871)
Offer Price (Qty.)
0.00 (0)
| Nine Months Results of RPG Life Sciences (in Rs. Cr.) | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
| Net Sales/Income from operations | 296.38 | 286.90 | 261.36 | 260.49 | 226.15 | |
| Other Operating Income | -- | -- | -- | -- | 6.41 | |
| Total Income From Operations | 296.38 | 286.90 | 261.36 | 260.49 | 232.56 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 67.69 | 56.96 | 41.64 | 50.43 | 44.73 | |
| Purchase of Traded Goods | 38.31 | 49.34 | 33.04 | 35.71 | 45.85 | |
| Increase/Decrease in Stocks | -7.53 | -9.06 | 12.12 | 1.83 | -9.85 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 71.86 | 72.22 | 70.02 | 65.27 | 56.53 | |
| Depreciation | 12.55 | 12.24 | 11.38 | 10.66 | 8.33 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 68.78 | 70.79 | 77.53 | 78.31 | 71.19 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 44.72 | 34.41 | 15.63 | 18.28 | 15.78 | |
| Other Income | 0.61 | 0.35 | 0.38 | 0.66 | 0.47 | |
| P/L Before Int., Excpt. Items & Tax | 45.33 | 34.76 | 16.01 | 18.94 | 16.25 | |
| Interest | 0.70 | 1.45 | 3.08 | 2.97 | 1.55 | |
| P/L Before Exceptional Items & Tax | 44.63 | 33.31 | 12.93 | 15.97 | 14.70 | |
| Exceptional Items | -- | -- | -- | -- | 7.38 | |
| P/L Before Tax | 44.63 | 33.31 | 12.93 | 15.97 | 22.08 | |
| Tax | 11.55 | 7.28 | 3.66 | 3.77 | 1.41 | |
| P/L After Tax from Ordinary Activities | 33.08 | 26.03 | 9.27 | 12.20 | 20.67 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 33.08 | 26.03 | 9.27 | 12.20 | 20.67 | |
| Equity Share Capital | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 20.00 | 15.74 | 5.61 | 7.38 | 12.50 | |
| Diluted EPS | 20.00 | 15.74 | 5.61 | 7.38 | 12.50 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 20.00 | 15.74 | 5.61 | 7.38 | 12.50 | |
| Diluted EPS. | 20.00 | 15.74 | 5.61 | 7.38 | 12.50 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
27.01.2021
RPG Life Standalone December 2020 Net Sales at Rs 107.60 crore, up 14.02% Y-o-Y
02.11.2020
RPG Life Sciences shifts gears, bets on chronic drugs to expand sales, profits
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.12.2019
Breakout buys: SBI, Hindalco among 10 stocks to consider for January series
27.01.2021
RPG Life Standalone December 2020 Net Sales at Rs 107.60 crore, up 14.02% Y-o-Y
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.07.2019
RPG Life Standalone June 2019 Net Sales at Rs 94.04 crore, up 17.71% Y-o-Y
30.04.2019
RPG Life Standalone March 2019 Net Sales at Rs 68.80 crore, down 17.57% Y-o-Y
